Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad) Buy SOLV Stock  Free SOLV Stock Alerts

Solventum (SOLV) Financials

Solventum logo
$73.50 +0.87 (+1.20%)
Closing price 06/20/2025 03:59 PM Eastern
Extended Trading
$73.58 +0.08 (+0.10%)
As of 06/20/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for Solventum

Annual Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 1,343 1,346 479
Consolidated Net Income / (Loss)		 1,343 1,346 479
Net Income / (Loss) Continuing Operations		 1,343 1,346 478
Total Pre-Tax Income 		1,692 1,667 605
Total Operating Income		 1,693 1,692 1,036
Total Gross Profit		 4,695 4,693 4,593
Total Revenue		 8,130 8,197 8,254
Operating Revenue		 8,130 8,197 8,254
Total Cost of Revenue		 3,435 3,504 3,661
Operating Cost of Revenue		 3,435 3,504 3,661
Total Operating Expenses		 3,002 3,001 3,557
Selling, General & Admin Expense		 2,235 2,243 2,782
Research & Development Expense		 767 758 775
Total Other Income / (Expense), net		 -1.00 -25 -431
Interest & Investment Income		 0.00 0.00 -367
Other Income / (Expense), net		 -1.00 -25 -64
Income Tax Expense		 349 321 127
Basic Earnings per Share		 $7.78 $7.79 $2.77
Weighted Average Basic Shares Outstanding		 172.70M 172.70M 173.20M
Diluted Earnings per Share		 $7.78 $7.79 $2.76
Weighted Average Diluted Shares Outstanding		 172.70M 172.70M 173.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - 172.99M

Quarterly Income Statements for Solventum

This table shows Solventum's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 293 321 460 272 237 89 122 31
Consolidated Net Income / (Loss)		 293 321 460 272 237 89 122 31
Net Income / (Loss) Continuing Operations		 293 321 460 272 237 89 122 30
Total Pre-Tax Income 		363 413 500 391 329 96 167 13
Total Operating Income		 365 417 504 406 381 244 275 136
Total Gross Profit		 1,137 1,189 1,209 1,158 1,172 1,137 1,165 1,119
Total Revenue		 2,011 2,076 2,074 2,036 2,016 2,081 2,082 2,075
Operating Revenue		 2,011 2,076 2,074 2,036 2,016 2,081 2,082 2,075
Total Cost of Revenue		 874 887 865 878 844 944 917 956
Operating Cost of Revenue		 874 887 865 878 844 944 917 956
Total Operating Expenses		 772 772 705 752 791 893 890 983
Selling, General & Admin Expense		 577 579 525 562 596 701 701 784
Research & Development Expense		 195 193 180 190 195 192 189 199
Total Other Income / (Expense), net		 -2.00 -4.00 -4.00 -15 -52 -148 -108 -123
Interest & Investment Income		 0.00 0.00 0.00 - -39 -114 -107 -107
Other Income / (Expense), net		 -2.00 -4.00 -4.00 -15 -13 -34 -1.00 -16
Income Tax Expense		 70 92 40 119 92 7.00 45 -17
Basic Earnings per Share		 $1.70 $1.86 $2.66 $1.57 $1.37 $0.51 $0.70 $0.19
Weighted Average Basic Shares Outstanding		 172.70M 172.70M 172.70M 172.70M 172.70M 173.20M 173.40M 173.20M
Diluted Earnings per Share		 $1.70 $1.86 $2.66 $1.57 $1.37 $0.51 $0.70 $0.18
Weighted Average Diluted Shares Outstanding		 172.70M 172.70M 172.70M 172.70M 172.70M 173.50M 173.90M 173.70M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 0.00 172.71M 172.71M 172.75M 172.99M

Annual Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 -30 133 568
Net Cash From Operating Activities		 1,679 1,915 1,185
Net Cash From Continuing Operating Activities		 1,679 1,915 1,185
Net Income / (Loss) Continuing Operations		 1,343 1,346 479
Consolidated Net Income / (Loss)		 1,343 1,346 479
Depreciation Expense		 578 561 555
Non-Cash Adjustments To Reconcile Net Income		 101 24 -419
Changes in Operating Assets and Liabilities, net		 -343 -16 570
Net Cash From Investing Activities		 -253 -230 -380
Net Cash From Continuing Investing Activities		 -253 -230 -380
Purchase of Property, Plant & Equipment		 -251 -290 -380
Divestitures		 0.00 60 0.00
Other Investing Activities, net		 -2.00 0.00 0.00
Net Cash From Financing Activities		 -1,460 -1,552 -240
Net Cash From Continuing Financing Activities		 -1,460 -1,552 -240
Repayment of Debt		 -4.00 1.00 -292
Issuance of Debt		 0.00 0.00 8,303
Other Financing Activities, net		 -1,456 -1,553 -8,251
Effect of Exchange Rate Changes		 4.00 0.00 3.00
Cash Interest Paid		 0.00 0.00 287
Cash Income Taxes Paid		 0.00 0.00 244

Quarterly Cash Flow Statements for Solventum

This table details how cash moves in and out of Solventum's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -18 -4.00 3.00 152 802 -99 -125 -10
Net Cash From Operating Activities		 509 366 493 547 442 355 169 219
Net Cash From Continuing Operating Activities		 509 366 493 547 442 355 169 219
Net Income / (Loss) Continuing Operations		 293 321 460 272 237 89 122 31
Consolidated Net Income / (Loss)		 293 321 460 272 237 89 122 31
Depreciation Expense		 145 133 144 139 139 133 133 150
Non-Cash Adjustments To Reconcile Net Income		 28 19 -40 17 13 -163 -126 -143
Changes in Operating Assets and Liabilities, net		 43 -107 -71 119 53 296 40 181
Net Cash From Investing Activities		 -65 -71 -6.00 -88 -102 -58 -93 -127
Net Cash From Continuing Investing Activities		 -65 -71 -6.00 -88 -102 -58 -93 -127
Purchase of Property, Plant & Equipment		 -65 -71 -66 -88 -102 -58 -93 -127
Net Cash From Financing Activities		 -462 -299 -485 -306 462 -396 -202 -104
Net Cash From Continuing Financing Activities		 -462 -299 -485 -306 462 -396 -202 -104
Repayment of Debt		 -2.00 2.00 2.00 -1.00 10 - -202 -100
Other Financing Activities, net		 -460 -301 -487 -305 -7,851 -396 - -4.00
Effect of Exchange Rate Changes		 0.00 - 1.00 -1.00 0.00 - 1.00 2.00

Annual Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024
Period end date 12/31/2023 12/31/2024
Total Assets		 13,943 14,457
Total Current Assets		 2,519 3,249
Cash & Equivalents		 194 762
Accounts Receivable		 1,313 1,229
Inventories, net		 857 965
Other Current Assets		 155 293
Plant, Property, & Equipment, net		 1,457 1,622
Total Noncurrent Assets		 9,967 9,586
Goodwill		 6,535 6,377
Intangible Assets		 2,902 2,544
Other Noncurrent Operating Assets		 530 665
Total Liabilities & Shareholders' Equity		 13,943 14,457
Total Liabilities		 2,277 11,498
Total Current Liabilities		 1,728 2,703
Short-Term Debt		 0.00 200
Accounts Payable		 477 618
Accrued Expenses		 0.00 272
Current Deferred Revenue		 574 572
Other Current Liabilities		 677 1,041
Total Noncurrent Liabilities		 549 8,795
Long-Term Debt		 0.00 7,810
Noncurrent Deferred & Payable Income Tax Liabilities		 231 225
Noncurrent Employee Benefit Liabilities		 166 350
Other Noncurrent Operating Liabilities		 152 410
Commitments & Contingencies		 0.00 0.00
Total Equity & Noncontrolling Interests		 11,666 2,959
Total Preferred & Common Equity		 11,666 2,959
Total Common Equity		 11,666 2,959
Common Stock		 0.00 3,773
Retained Earnings		 0.00 242
Accumulated Other Comprehensive Income / (Loss)		 -337 -1,056
Other Equity Adjustments		 12,003 0.00

Quarterly Balance Sheets for Solventum

This table presents Solventum's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Total Assets		 13,943 14,711 14,578 14,745 14,457
Total Current Assets		 2,519 3,359 3,363 3,354 3,249
Cash & Equivalents		 194 996 897 772 762
Accounts Receivable		 1,313 1,220 1,317 1,327 1,229
Inventories, net		 857 901 899 953 965
Other Current Assets		 155 242 250 302 293
Plant, Property, & Equipment, net		 1,457 1,491 1,537 1,599 1,622
Total Noncurrent Assets		 9,967 9,861 9,678 9,792 9,586
Goodwill		 6,535 6,468 6,447 6,592 6,377
Intangible Assets		 2,902 2,810 2,724 2,651 2,544
Other Noncurrent Operating Assets		 530 583 507 549 665
Total Liabilities & Shareholders' Equity		 13,943 14,711 14,578 14,745 14,457
Total Liabilities		 2,277 10,860 11,711 11,553 11,498
Total Current Liabilities		 1,728 1,854 2,571 2,904 2,703
Short-Term Debt		 0.00 - - 300 200
Accounts Payable		 477 587 495 560 618
Accrued Expenses		 0.00 - 611 450 272
Current Deferred Revenue		 574 566 505 563 572
Other Current Liabilities		 677 701 960 1,031 1,041
Total Noncurrent Liabilities		 549 9,006 9,140 8,649 8,795
Long-Term Debt		 0.00 8,303 8,306 7,809 7,810
Noncurrent Deferred & Payable Income Tax Liabilities		 231 211 214 214 225
Noncurrent Employee Benefit Liabilities		 166 321 315 321 350
Other Noncurrent Operating Liabilities		 152 171 305 305 410
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 11,666 3,851 2,867 3,192 2,959
Total Preferred & Common Equity		 11,666 3,851 2,867 3,192 2,959
Total Common Equity		 11,666 3,851 2,867 3,192 2,959
Common Stock		 0.00 - 3,721 3,746 3,773
Retained Earnings		 0.00 - 89 211 242
Accumulated Other Comprehensive Income / (Loss)		 -337 -958 -943 -765 -1,056
Other Equity Adjustments		 12,003 4,809 0.00 0.00 0.00

Annual Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric 2022 2023 2024
Period end date 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - -
Revenue Growth		 0.00% 0.82% 0.70%
EBITDA Growth		 0.00% -1.85% -31.46%
EBIT Growth		 0.00% -1.48% -41.69%
NOPAT Growth		 0.00% 1.67% -40.09%
Net Income Growth		 0.00% 0.22% -64.41%
EPS Growth		 0.00% 0.13% -64.57%
Operating Cash Flow Growth		 0.00% 14.06% -38.12%
Free Cash Flow Firm Growth		 0.00% 0.00% 120.62%
Invested Capital Growth		 0.00% 0.00% -11.03%
Revenue Q/Q Growth		 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% -3.06%
Profitability Metrics		 - - -
Gross Margin		 57.75% 57.25% 55.65%
EBITDA Margin		 27.92% 27.18% 18.50%
Operating Margin		 20.82% 20.64% 12.55%
EBIT Margin		 20.81% 20.34% 11.78%
Profit (Net Income) Margin		 16.52% 16.42% 5.80%
Tax Burden Percent		 79.37% 80.74% 79.17%
Interest Burden Percent		 100.00% 100.00% 62.24%
Effective Tax Rate		 20.63% 19.26% 20.99%
Return on Invested Capital (ROIC)		 0.00% 23.82% 7.55%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 44.63% -2.08%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -0.74% -1.00%
Return on Equity (ROE)		 0.00% 23.08% 6.55%
Cash Return on Invested Capital (CROIC)		 0.00% -176.18% 19.22%
Operating Return on Assets (OROA)		 0.00% 11.96% 6.85%
Return on Assets (ROA)		 0.00% 9.65% 3.37%
Return on Common Equity (ROCE)		 0.00% 23.08% 6.55%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 11.54% 16.19%
Net Operating Profit after Tax (NOPAT)		 1,344 1,366 819
NOPAT Margin		 16.53% 16.67% 9.92%
Net Nonoperating Expense Percent (NNEP)		 0.00% -20.81% 9.63%
Return On Investment Capital (ROIC_SIMPLE)		 - 11.71% 7.46%
Cost of Revenue to Revenue		 42.25% 42.75% 44.35%
SG&A Expenses to Revenue		 27.49% 27.36% 33.70%
R&D to Revenue		 9.43% 9.25% 9.39%
Operating Expenses to Revenue		 36.93% 36.61% 43.09%
Earnings before Interest and Taxes (EBIT)		 1,692 1,667 972
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 2,270 2,228 1,527
Valuation Ratios		 - - -
Price to Book Value (P/BV)		 0.00 0.00 3.86
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 1.38
Price to Earnings (P/E)		 0.00 0.00 23.82
Dividend Yield		 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 4.20%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 1.83
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 2.26
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 12.22
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 19.20
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 22.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 15.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 8.96
Leverage & Solvency		 - - -
Debt to Equity		 0.00 0.00 2.71
Long-Term Debt to Equity		 0.00 0.00 2.64
Financial Leverage		 0.00 -0.02 0.48
Leverage Ratio		 0.00 1.20 1.94
Compound Leverage Factor		 0.00 1.20 1.21
Debt to Total Capital		 0.00% 0.00% 73.02%
Short-Term Debt to Total Capital		 0.00% 0.00% 1.82%
Long-Term Debt to Total Capital		 0.00% 0.00% 71.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 100.00% 26.98%
Debt to EBITDA		 0.00 0.00 5.25
Net Debt to EBITDA		 0.00 0.00 4.75
Long-Term Debt to EBITDA		 0.00 0.00 5.11
Debt to NOPAT		 0.00 0.00 9.79
Net Debt to NOPAT		 0.00 0.00 8.85
Long-Term Debt to NOPAT		 0.00 0.00 9.54
Altman Z-Score		 0.00 0.00 1.46
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00%
Liquidity Ratios		 - - -
Current Ratio		 0.00 1.46 1.20
Quick Ratio		 0.00 0.87 0.74
Cash Flow Metrics		 - - -
Free Cash Flow to Firm (FCFF)		 0.00 -10,106 2,084
Operating Cash Flow to CapEx		 668.92% 660.34% 311.84%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00
Efficiency Ratios		 - - -
Asset Turnover		 0.00 0.59 0.58
Accounts Receivable Turnover		 0.00 6.24 6.49
Inventory Turnover		 0.00 4.09 4.02
Fixed Asset Turnover		 0.00 5.63 5.36
Accounts Payable Turnover		 0.00 7.35 6.69
Days Sales Outstanding (DSO)		 0.00 58.47 56.20
Days Inventory Outstanding (DIO)		 0.00 89.27 90.83
Days Payable Outstanding (DPO)		 0.00 49.69 54.59
Cash Conversion Cycle (CCC)		 0.00 98.05 92.45
Capital & Investment Metrics		 - - -
Invested Capital		 0.00 11,472 10,207
Invested Capital Turnover		 0.00 1.43 0.76
Increase / (Decrease) in Invested Capital		 0.00 11,472 -1,265
Enterprise Value (EV)		 0.00 0.00 18,660
Market Capitalization		 0.00 0.00 11,412
Book Value per Share		 $0.00 $67.55 $17.13
Tangible Book Value per Share		 $0.00 $12.91 ($34.51)
Total Capital		 0.00 11,666 10,969
Total Debt		 0.00 0.00 8,010
Total Long-Term Debt		 0.00 0.00 7,810
Net Debt		 0.00 -194 7,248
Capital Expenditures (CapEx)		 251 290 380
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 597 -16
Debt-free Net Working Capital (DFNWC)		 0.00 791 746
Net Working Capital (NWC)		 0.00 791 546
Net Nonoperating Expense (NNE)		 0.79 20 340
Net Nonoperating Obligations (NNO)		 0.00 -194 7,248
Total Depreciation and Amortization (D&A)		 578 561 555
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 7.28% -0.19%
Debt-free Net Working Capital to Revenue		 0.00% 9.65% 9.04%
Net Working Capital to Revenue		 0.00% 9.65% 6.62%
Earnings Adjustments		 - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $2.77
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 173.20M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $2.76
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 173.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 172.99M
Normalized Net Operating Profit after Tax (NOPAT)		 1,344 1,366 819
Normalized NOPAT Margin		 16.53% 16.67% 9.92%
Pre Tax Income Margin		 20.81% 20.34% 7.33%
Debt Service Ratios		 - - -
EBIT to Interest Expense		 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00
Payout Ratios		 - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Solventum

This table displays calculated financial ratios and metrics derived from Solventum's official financial filings.

Metric Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 0.25% 0.24% 0.39% 1.92%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% -0.20% -37.18% -36.80% -49.06%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% 1.38% -49.15% -45.20% -69.31%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% -6.84% -30.21% -56.67% 11.12%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% -19.11% -72.27% -73.48% -88.60%
EPS Growth		 0.00% 0.00% 0.00% 0.00% -19.41% -72.58% -73.68% -88.54%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% -13.16% -3.01% -65.72% -59.96%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -11.03%
Revenue Q/Q Growth		 0.00% 3.23% -0.10% -1.83% 0.00% 3.22% 0.05% -0.34%
EBITDA Q/Q Growth		 0.00% 7.48% 17.95% -17.70% 0.00% -32.35% 18.66% -33.66%
EBIT Q/Q Growth		 0.00% 13.77% 21.07% -21.80% 0.00% -42.93% 30.48% -56.20%
NOPAT Q/Q Growth		 0.00% 10.01% 43.06% -39.09% 0.00% -17.58% -11.19% 56.22%
Net Income Q/Q Growth		 0.00% 9.56% 43.30% -40.87% 0.00% -62.45% 37.08% -74.59%
EPS Q/Q Growth		 0.00% 9.41% 43.01% -40.98% 0.00% -62.77% 37.25% -74.29%
Operating Cash Flow Q/Q Growth		 0.00% -28.09% 34.70% 10.95% 0.00% -19.68% -52.39% 29.59%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 7.66% -2.77% 115.29%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -7.90% 2.46% -3.06%
Profitability Metrics		 - - - - - - - -
Gross Margin		 56.54% 57.27% 58.29% 56.88% 58.13% 54.64% 55.96% 53.93%
EBITDA Margin		 25.26% 26.30% 31.05% 26.03% 25.15% 16.48% 19.55% 13.01%
Operating Margin		 18.15% 20.09% 24.30% 19.94% 18.90% 11.73% 13.21% 6.55%
EBIT Margin		 18.05% 19.89% 24.11% 19.20% 18.25% 10.09% 13.16% 5.78%
Profit (Net Income) Margin		 14.57% 15.46% 22.18% 13.36% 11.76% 4.28% 5.86% 1.49%
Tax Burden Percent		 80.72% 77.72% 92.00% 69.57% 72.04% 92.71% 73.05% 238.46%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 89.40% 45.71% 60.95% 10.83%
Effective Tax Rate		 19.28% 22.28% 8.00% 30.43% 27.96% 7.29% 26.95% -130.77%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 9.91% 0.00% 0.00% 0.00% 11.52%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 15.29% 0.00% 0.00% 0.00% 3.50%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% -0.25% 0.00% 0.00% 0.00% 1.69%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 9.66% 0.00% 0.00% 0.00% 13.20%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% -88.09% 0.00% 0.00% 0.00% 19.22%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 11.29% 0.00% 0.00% 0.00% 3.36%
Return on Assets (ROA)		 0.00% 0.00% 0.00% 7.85% 0.00% 0.00% 0.00% 0.87%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 9.66% 0.00% 0.00% 0.00% 13.20%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 295 324 464 282 274 226 201 314
NOPAT Margin		 14.65% 15.61% 22.36% 13.87% 13.61% 10.87% 9.65% 15.13%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% -5.38% 1.03% 3.70% 2.15% 8.02%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 2.42% - - - 2.86%
Cost of Revenue to Revenue		 43.46% 42.73% 41.71% 43.12% 41.87% 45.36% 44.04% 46.07%
SG&A Expenses to Revenue		 28.69% 27.89% 25.31% 27.60% 29.56% 33.69% 33.67% 37.78%
R&D to Revenue		 9.70% 9.30% 8.68% 9.33% 9.67% 9.23% 9.08% 9.59%
Operating Expenses to Revenue		 38.39% 37.19% 33.99% 36.94% 39.24% 42.91% 42.75% 47.37%
Earnings before Interest and Taxes (EBIT)		 363 413 500 391 368 210 274 120
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 508 546 644 530 507 343 407 270
Valuation Ratios		 - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 3.19 3.77 3.86
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 1.38
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 23.82
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 4.20%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 1.61 1.84 1.83
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.26
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 12.22
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 19.20
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 22.80
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 15.75
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.96
Leverage & Solvency		 - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 2.16 2.90 2.54 2.71
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 2.16 2.90 2.45 2.64
Financial Leverage		 0.00 0.00 0.00 -0.02 1.90 2.58 2.30 0.48
Leverage Ratio		 0.00 0.00 0.00 1.20 3.82 5.08 4.62 1.94
Compound Leverage Factor		 0.00 0.00 0.00 1.20 3.42 2.32 2.82 0.21
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 68.32% 74.34% 71.75% 73.02%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 2.65% 1.82%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 68.32% 74.34% 69.10% 71.20%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 0.00% 0.00% 0.00% 100.00% 31.69% 25.66% 28.25% 26.98%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.25
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.75
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.11
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.79
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 8.85
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.54
Altman Z-Score		 0.00 0.00 0.00 0.00 0.00 0.59 0.74 1.26
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - -
Current Ratio		 0.00 0.00 0.00 1.46 1.81 1.31 1.16 1.20
Quick Ratio		 0.00 0.00 0.00 0.87 1.20 0.86 0.72 0.74
Cash Flow Metrics		 - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -10,884 -10,050 -10,328 1,579
Operating Cash Flow to CapEx		 783.08% 515.49% 746.97% 621.59% 433.33% 612.07% 181.72% 172.44%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 0.59 0.00 0.00 0.00 0.58
Accounts Receivable Turnover		 0.00 0.00 0.00 6.24 0.00 0.00 0.00 6.49
Inventory Turnover		 0.00 0.00 0.00 4.09 0.00 0.00 0.00 4.02
Fixed Asset Turnover		 0.00 0.00 0.00 5.63 0.00 0.00 0.00 5.36
Accounts Payable Turnover		 0.00 0.00 0.00 7.35 0.00 0.00 0.00 6.69
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 58.47 0.00 0.00 0.00 56.20
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 89.27 0.00 0.00 0.00 90.83
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 49.69 0.00 0.00 0.00 54.59
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 98.05 0.00 0.00 0.00 92.45
Capital & Investment Metrics		 - - - - - - - -
Invested Capital		 0.00 0.00 0.00 11,472 11,158 10,276 10,529 10,207
Invested Capital Turnover		 0.00 0.00 0.00 0.71 0.00 0.00 0.00 0.76
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 11,158 10,276 10,529 -1,265
Enterprise Value (EV)		 0.00 0.00 0.00 0.00 0.00 16,542 19,378 18,660
Market Capitalization		 0.00 0.00 0.00 0.00 0.00 9,133 12,041 11,412
Book Value per Share		 $0.00 $0.00 $0.00 $67.55 $22.30 $16.60 $18.48 $17.13
Tangible Book Value per Share		 $0.00 $0.00 $0.00 $12.91 ($31.42) ($36.50) ($35.04) ($34.51)
Total Capital		 0.00 0.00 0.00 11,666 12,154 11,173 11,301 10,969
Total Debt		 0.00 0.00 0.00 0.00 8,303 8,306 8,109 8,010
Total Long-Term Debt		 0.00 0.00 0.00 0.00 8,303 8,306 7,809 7,810
Net Debt		 0.00 0.00 0.00 -194 7,307 7,409 7,337 7,248
Capital Expenditures (CapEx)		 65 71 66 88 102 58 93 127
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 597 509 -105 -22 -16
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 791 1,505 792 750 746
Net Working Capital (NWC)		 0.00 0.00 0.00 791 1,505 792 450 546
Net Nonoperating Expense (NNE)		 1.61 3.11 3.68 10 37 137 79 283
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 -194 7,307 7,409 7,337 7,248
Total Depreciation and Amortization (D&A)		 145 133 144 139 139 133 133 150
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 7.28% 0.00% 0.00% 0.00% -0.19%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 9.65% 0.00% 0.00% 0.00% 9.04%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 9.65% 0.00% 0.00% 0.00% 6.62%
Earnings Adjustments		 - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 $1.57 $1.37 $0.51 $0.70 $0.19
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 172.70M 172.70M 173.20M 173.40M 173.20M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 $1.57 $1.37 $0.51 $0.70 $0.18
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 172.70M 172.70M 173.50M 173.90M 173.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 0.00 172.71M 172.71M 172.75M 172.99M
Normalized Net Operating Profit after Tax (NOPAT)		 295 324 464 282 274 226 201 95
Normalized NOPAT Margin		 14.65% 15.61% 22.36% 13.87% 13.61% 10.87% 9.65% 4.59%
Pre Tax Income Margin		 18.05% 19.89% 24.11% 19.20% 16.32% 4.61% 8.02% 0.63%
Debt Service Ratios		 - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Key Financial Trends

Solventum’s Q4 2024 results show modest revenue growth but significant pressure on profits and cash flow compared with a year ago. Key drivers include ongoing investments in R&D and continued leverage on the balance sheet.

  • Revenue Growth: Operating revenue rose 1.9% year-over-year in Q4 2024 to $2.075 billion.
  • NOPAT Improvement: Net operating profit after tax increased 11.1% to $313.8 million in Q4 2024 versus Q4 2023.
  • Invested Capital Turnover: Turnover improved to 0.7615 in Q4 2024 from 0.7145, indicating more efficient use of invested capital.
  • FCFF Generation: Free cash flow to the firm rose to $1.58 billion in Q4 2024, reflecting strong cash conversion.
  • Share Count: Weighted average shares outstanding remained stable near 173 million, limiting dilution.
  • Dividend Policy: No dividend was paid in Q4 2024, consistent with prior periods.
  • Net Income Decline: Consolidated net income fell sharply to $31 million in Q4 2024 from $272 million in Q4 2023.
  • EPS Compression: Diluted EPS dropped to $0.18 in Q4 2024 versus $1.57 a year earlier.
  • Operating Income Pressure: Operating income plunged to $136 million in Q4 2024 from $406 million in Q4 2023.
  • Cash Flow Reduction: Net cash from operating activities declined to $219 million in Q4 2024 from $547 million in the prior year’s quarter.
  • High Leverage: Net debt to EBITDA remains elevated at 4.75×, underscoring balance-sheet risk.
06/21/25 02:41 PMAI Generated. May Contain Errors.

Frequently Asked Questions About Solventum's Financials

When does Solventum's fiscal year end?

According to the most recent income statement we have on file, Solventum's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Solventum's net income changed over the last 2 years?

Solventum's net income appears to be on a downward trend, with a most recent value of $479 million in 2024, falling from $1.34 billion in 2022. The previous period was $1.35 billion in 2023. View Solventum's forecast to see where analysts expect Solventum to go next.

What is Solventum's operating income?
Solventum's total operating income in 2024 was $1.04 billion, based on the following breakdown:
  • Total Gross Profit: $4.59 billion
  • Total Operating Expenses: $3.56 billion
How has Solventum's revenue changed over the last 2 years?

Over the last 2 years, Solventum's total revenue changed from $8.13 billion in 2022 to $8.25 billion in 2024, a change of 1.5%.

How much debt does Solventum have?

Solventum's total liabilities were at $11.50 billion at the end of 2024, a 405.0% increase from 2023, and a 405.0% increase since 2023.

How much cash does Solventum have?

In the past 1 years, Solventum's cash and equivalents has ranged from $194 million in 2023 to $762 million in 2024, and is currently $762 million as of their latest financial filing in 2024.

How has Solventum's book value per share changed over the last 2 years?

Over the last 2 years, Solventum's book value per share changed from 0.00 in 2022 to 17.13 in 2024, a change of 1,712.8%.


Related Companies

This page (NYSE:SOLV) was last updated on 6/21/2025 by MarketBeat.com Staff
From Our Partners
Trump’s Exec Order #14154 could be a “Millionaire-Maker”
Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...
Paradigm Press | Sponsored
An AI run of epic proportions is only getting started
I just put together an urgent new presentation that you need to see right away. In short: I believe we are...
Timothy Sykes | Sponsored
Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...
Brownstone Research | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...
Weiss Ratings | Sponsored
Elon’s NEXT Big IPO?
Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...
Banyan Hill Publishing | Sponsored
A new rule goes live in July — and the banks are quietly cashing in
A major change is quietly going into effect this July — and Wall Street is already positioning for it. Big ...
American Alternative | Sponsored
The IRS Loophole That Lets You Own Gold Tax-Free
What if I told you there's a legal way to own real physical gold and silver—and keep your gains tax-free? N...
Advantage Gold | Sponsored